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PCNA is a ring-shaped protein that encircles DNA, providing a platform for the
association of a wide variety of DNA-processing enzymes that utilize the PCNA
sliding clamp to maintain proximity to their DNA substrates. PCNA is a
homotrimer in eukaryotes, but a heterotrimer in crenarchaea such as Sulfolobus
solfataricus. The three proteins are SsoPCNA1 (249 residues), SsoPCNA2 (245
residues) and SsoPCNA3 (259 residues). The heterotrimeric protein crystallizes
in space group P21, with unit-cell parameters a = 44.8, b = 78.8, c = 125.6 A ˚ ,
  = 100.5 . The crystal structure of this heterotrimeric PCNA molecule has been
solved using molecular replacement. The resulting structure to 2.3 A ˚ sheds light
on the differential stabilities of the interactions observed between the three
subunits and the speciﬁcity of individual subunits for partner proteins.
1. Introduction
PCNA (proliferating cell nuclear antigen) is a trimeric ring-shaped
protein that encircles DNA. PCNA acts as a processivity factor, or
sliding clamp, for a wide variety of proteins that act on DNA,
including DNA polymerases, DNA ligase, endonucleases and glyco-
sylases (reviewed in Warbrick, 2000). In general, these are proteins
that act on DNA structures rather than binding to speciﬁc sequences
and PCNA is thought to help maintain contact with DNA over
thousands of nucleotides (Kelman & Hurwitz, 1998). Partner proteins
interact with PCNA via a PIP-box peptide that makes contact with
the interdomain-connecting loop (IDCL) of PCNA (Fig. 1) and up to
three different proteins could potentially be loaded onto a single
PCNA trimer simultaneously, suggesting that PCNA can act as a
molecular ‘tool-belt’.
PCNA is conserved in the archaea, which have information-
processing pathways that are often simpliﬁed versions of those found
in eukaryotes. Whilst most archaea encode a homotrimeric PCNA
molecule like the eukaryotic version, the crenarchaeote Sulfolobus
solfataricus and other Sulfolobus species possess a heterotrimeric
PCNA (SsoPCNA; Dionne et al., 2003). This increased complexity
allows the opportunity for each subunit to evolve selectivity for
binding partners and this has been shown to be the case (Dionne et
al., 2003; Dionne & Bell, 2005; Roberts et al., 2003). The hetero-
trimeric structure of SsoPCNA assembles via a strong interaction
between PCNA subunits 1 and 2, followed by a much weaker inter-
action with subunit 3 to complete the circle (Dionne et al., 2003), and
clamp-loading machinery is not required in vitro for assembly on
DNA substrates with blocked ends (Roberts & White, 2005). Here,
we report the crystal structure of the PCNA heterotrimer from
S. solfataricus to 2.3 A ˚ .
2. Experimental procedures
The three subunits of PCNA from S. solfataricus were expressed in
Escherichia coli from expression plasmids obtained from the
laboratory of Dr Stephen Bell (Dionne et al., 2003). SsoPCNA1,
SsoPCNA2 and SsoPCNA3 were overexpressed using the same
conditions. E. coli Rosetta (DE3) cells, a BL21 (DE3) derivative
which contains a plasmid (pRARE) containing the six rare-codon
tRNAs for the codons AGG, AGA, AUA, CUA, CCC and GGA,
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All rights reservedwere transformed with plasmid DNA encoding the target protein.
The Rosetta (DE3) cell line enhances the expression of genes in
E. coli that contain codons not commonly found in E. coli. Single
colonies were grown in 10 ml LB supplemented with 50 mgm l
 1
kanamycin overnight. Overnight cultures were used to inoculate
500 ml LB supplemented with 50 mgm l
 1 kanamycin in 2 l ﬂasks.
Cells were grown to an OD600 of 0.8–1.0 at 310 K and then induced
with 0.2 mM isopropyl  -d-thiogalactopyranoside at 291 Kovernight.
Cells were harvested at 10 500g and resuspended in equilibration
buffer (50 mM HEPES pH 8.0, 10 mM imidazole and 300 mM NaCl).
Soluble proteins were extracted by incubation at room temperature
for 1 h with 100 mgm l
 1 lysozyme and 20 mgm l
 1 DNase (Sigma),
followed by two passes through a constant cell disruptor (Constant
systems) and subsequent centrifugation for 30 min at 75 500g.T h e
puriﬁcation protocols of SsoPCNA1, SsoPCNA2 and SsoPCNA3 are
essentially identical. Supernatant containing target protein was
applied onto a charged HisTrap Nickel Sepharose high-performance
column (GE Healthcare) pre-equilibrated with equilibration buffer
and weakly bound proteins were removed by extensive washing with
buffer containing 50 mM and then 100 mM imidazole. Essentially
pure target protein was eluted with 250 mM imidazole, dialyzed into
50 mM HEPES pH 8.0 containing 250 mM NaCl and further puriﬁed
by Superdex S200 gel-ﬁltration chromatography (GE Healthcare).
The three PCNA subunits were then mixed in an approximately
equimolar ratio and incubated at room temperature for 1 h; the
PCNA heterotrimer was then puriﬁed by S200 gel ﬁltration. Each
step of puriﬁcation was monitored by SDS–PAGE. After the gel-
ﬁltration step proteins were judged to be pure by Coomassie-stained
gels and their integrity was conﬁrmed by mass spectrometry. The pure
PCNA heterotrimer was concentrated to 15 mg ml
 1 and dialyzed
into 20 mM HEPES pH 7.5, 20 mM NaCl and 2 mM DTT prior to
crystallization.
The protein was screened for crystallization in sitting-drop vapour-
diffusion experiments using a Cartesian nano-dispensing robot
(Genomic Solutions) against a wide range of sparse-matrix screens.
Conditions which gave crystals were scaled up and optimized by
systematic variation of the conditions. The best crystals were
obtained from sitting-drop vapour diffusion of 1 ml protein solution
with 1 ml 7.5% PEG 20 000 against a 100 ml reservoir of 7.5% PEG
20 000. The crystals form thin sheets that cluster together. However,
careful manipulation allowed the removal of a single crystal, which
was cryoprotected with 20% (2R,3R)-( )2,3-butanediol (Sigma)
prior to X-ray diffraction at 100 K. Data to 2.3 A ˚ were collected on a
single PCNA heterotrimer crystal at Daresbury synchrotron-
radiation source, beamline 14.1. 350 diffraction images with 0.4 
oscillation range were collected using a Quantum 4 ADSC detector,
an exposure time of 25 s and a crystal-to-detector distance of 95 mm,
with a wavelength of 1.488 A ˚ . Data were indexed and scaled with
HKL-2000 (Otwinowski & Minor, 1997). Full details are given in
Table 1; no cutoff was applied and the Wilson B factor is estimated as
46 A ˚ 2. The structure was solved by molecular replacement using
Phaser (McCoy et al., 2005; Storoni et al., 2004) as implemented in
CCP4 (Collaborative Computational Project, Number 4, 1994) using
the monomer from S. tokadaii (PDB code 1ud9) as the search model.
Each subunit was found separately, with Z scores of 9.1 (SsoPCNA1),
10.4 (SsoPCNA2) and 8.1 (SsoPCNA3). The structure was reﬁned
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Figure 1
Sequence alignment of the three SsoPCNA subunits with the single PCNA proteins from Pyrococcus furiosus and Homo sapiens. Highly conserved residues are highlighted
in black and conservatively substituted residues in grey. The interdomain-connecting loop (IDCL) is indicated by asterisks, highlighting the three-residue insertion present in
SsoPCNA1. The sequence given for SsoPCNA3 is that used in this study and is based on its original annotation in the public database. The second M (residue 16) is probably
the correct start site. Accession Nos.: SsoPCNA1, P57766; SsoPCNA2, Q97Z84; SsoPCNA3, P57765; StoPCNA3, Q975N2; P. furiosus PyrfuPCNA, O73947; human PCNA,
P12004.using REFMAC5 (Murshudov et al., 1997, 1999) and manually rebuilt
with Coot (Emsley & Cowtan, 2004). The simulated-annealing
protocol in CNS (Bru ¨nger et al., 1998) and XFIT (McRee, 1999) were
used to help with ﬁtting difﬁcult loops. The structure was examined
with MOLPROBITY (Davis et al., 2004). The number of residues
observed for chains A, B and C were 226, 245 and 241, respectively.
Chain A is missing the N-terminal methionine, three short loops
comprising residues 84–85, 93–95 and 172–175 and the long IDCL
comprising residues 117–130. Chain B is complete, whereas chain C is
missing the ﬁrst nine N-terminal residues and two short loops
comprising residues 183–186 and 197–201. In addition, the structure
contains 121 modelled water molecules. Figures were produced with
the CCP4 viewer (Potterton et al., 2004).
3. Results
The structure consists of three monomers, SsoPCNA1, SsoPCNA2
and SsoPCNA3 (denoted monomers A, B and C, respectively, in the
crystal structure), which share only  22% sequence identity
(Table 2). The three monomers share a similar fold, although there
are important differences in detail which are discussed later. Each
monomer of SsoPCNA has two domains which are themselves
structural duplicates. The fold of the monomer (and domains) is
unchanged from the description of the yeast protomer (Krishna et al.,
1994). Brieﬂy, each monomer has two lobes. Each lobe is shaped like
a triangle, with two sides being formed by  -sheets and one by two
 -helices. One of the  -sheets pairs with the  -sheet of the other
domain, making an extended  -sheet (Fig. 2). The SsoPCNA
heterotrimer has the same apparent threefold symmetry observed in
the homotrimeric structure ﬁrst found in the structure from yeast
protein structure communications
946 Williams et al.   PCNA Acta Cryst. (2006). F62, 944–948
Table 1
Crystallographic data for SsoPCNA.
Values in parentheses refer to the highest resolution shell.
Beamline Daresbury 14.1
Wavelength (A ˚ ) 1.48
Resolution (A ˚ ) 60.00–2.20 (2.28–2.20)
Space group P21
Temperature (K) 100
Detector Quantum 4 ADSC
Unit-cell parameters (A ˚ ,  ) a = 44.8, b = 78.8, c = 125.6,
  =   = 90,   = 100.5
Solvent content (%) 52.48
Unique reﬂections 43983 (4117)
I/ (I) 13.4 (1.9)
Average redundancy 2.3 (2.2)
Data completeness (%) 91.2 (93.9)
Rmerge† (%) 0.060 (0.384)
Reﬁnement
R factor (%) 21.7 (24.3)
Rfree (%) 27.3 (28.7)
R.m.s.d. bond distance (A ˚ ) 0.015
R.m.s.d. bond angle ( ) 1.35
Average B factors (A ˚ 2)
Main chain 54.63
Side chain 55.89
Solvent 54.44
Ramachandran plot (%)
Core 98
Disallowed 0
No. of protein atoms 5583
No. of solvent atoms 121
PDB code 2ix2
† Rmerge =
PP
IðhÞi  h IðhÞij=
P
IðhÞi, where I(h) is the measured diffraction intensity
and the summation includes all observations. † R factor = P   jFoj j Fcj
   =
P
jFoj.‡ Rfree is calculated the same way as R factor for data omitted
from reﬁnement (5% of reﬂections for all data sets).
Figure 2
(a) A stereoview ribbon representation of the SsoPCNA hetereotrimer. SsoPCNA1 is coloured green, SsoPCNA2 yellow and SsoPCNA3 magenta. This view looks down on
the ‘top’ of the structure. The IDCL is marked with a 1 for SSoPCNA1, 2 for SSoPCNA2 and 3 for SsoPCNA3. (b) The molecule has been rotated 90  relative to the
orientation in (a).
Table 2
The sequence identity/similarity (%) between PCNA molecules.
SsoPCNA1 SsoPCNA2 SsoPCNA3 huPCNA StoPCNA3 PyrfuPCNA
SsoPCNA1 24/39 17/39 16/42 20/40 21/43
SsoPCNA2 23/48 21/45 26/51 31/54
SsoPCNA3 24/46 61/82 31/56
huPCNA 23/47 24/48
StoPCNA3 29/52(Krishna et al., 1994). In the heterotrimer, the threefold symmetry is
not perfect. The apparent ‘threefold’ rotational symmetry of the
trimer means that each PCNA molecule interacts with the other two
monomers (Fig. 2). The N-terminal lobe of SsoPCNA1 interacts with
the C-terminal lobe of SsoPCNA3, the C-terminal lobe of SsoPCNA1
with the N-terminal lobe of SsoPCNA2 and the C-terminal lobe of
SsoPCNA2 with the N-terminal lobe of SsoPCNA3. There are no
solvent molecules which mediate the contacts between the subunits.
We deﬁne the top of the ring as the face where the C-termini are
located (Fig. 2).
In each of the three monomers, about 100 C
  atoms of the
N-terminal domain can be superimposed with a root-mean-square
deviation (r.m.s.d.) of 2.0 A ˚ on the C-terminal domain. This gives the
heterotrimer a pseudo-sixfold symmetric appearance. The complete
monomers of SsoPCNA2 and SsoPCNA3 are well ordered, but the
N-terminal 120 residues (essentially the N-terminal lobe) of
SsoPCNA1 are only weakly ordered, suggesting this domain is mobile
in the complex. Comparing the monomers reveals (Table 3) that
SsoPCNA1 stands out as distinct from the other monomers (even if
superposition is restricted to domains). Comparison of the monomers
with a recent structure of the homotrimeric human PCNA molecule
(huPCNA; PDB code 1vym; Kontopidis et al., 2005) reveals that the
three monomers are almost equally distinct from huPCNA (r.m.s.d.s
of 1.9, 1.8 and 1.7 A ˚ for SsoPCNA1, SsoPCNA2 and SsoPCNA3,
respectively). The same conclusion is reached if one superimposes
domains rather than monomers. The S. tokadaii PCNA3 (StoPCNA3)
monomer (PDB code 1ud9; Matsumiya et al., 2001) is of course most
similar to SsoPCNA3, but once again it is SsoPCNA1 which is
structurally distinct. StoPCNA3 is found as a homodimer in its crystal
structure, which has no relation to the biological heterotrimeric
structure observed in vivo (Dionne et al., 2003).
The entire SsoPCNA heterotrimer can be superimposed onto
huPCNAwith an r.m.s.d. of 2.2 A ˚ for 640 C
  atoms. However, if only
SsoPCNA1 (or SsoPCNA2) is used in calculating the superposition, it
can be seen that the SsoPCNA3 is shifted with respect to the ring
structure (Fig. 3). The shift is both a translation and rotation; the
effect is that SsoPCNA3 sits around 4 A ˚ above the ring in the
heterotrimer compared with the huPCNA homotrimer (Fig. 3). This
displacement of SsoPCNA3 is manifested in the interfaces in the
heterotrimer. The CCP4 Protein Interfaces, Surfaces and Assemblies
(PISA) server at the European Bioinformatic Institute (EBI; http://
www.ebi.ac.uk/msd-srv/prot_int/pistart.html) is a powerful tool for
assessing the thermodynamics of interface formation based on
structural data (Krissinel & Henrick, 2005). The program also
computes a signiﬁcance score which has been derived from an
analysis of the known complexes in the Protein Data Bank. This tool
shows the SsoPCNA1–SsoPCNA2 interface is largely hydrophobic
(and thus favourable) and has a number of speciﬁc hydrogen bonds.
The interface has a signiﬁcance of 1 (the highest), indicating the
complex is stable and essential for the formation of the trimer. This is
in agreement with biological data, which indicated that the
SsoPCNA1 and SsoPCNA2 subunits form a stable dimer in solution
(Dionne et al., 2003). The SsoPCNA2–SsoPCNA3 interface, despite
burying a similar amount of surface area to the SsoPCNA1–
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Table 3
Structural similarity between PCNA molecules.
The r.m.s.d. (A ˚ ) and number of C
  atoms are listed. The values were calculated using
secondary-structure matching as implemented in CCP4 (Collaborative Computational
Project, Number 4, 1994).
SsoPCNA1 SsoPCNA2 SsoPCNA3 huPCNA StoPCNA3
SsoPCNA1 2.0/210 2.2/203 1.9/214 2.1/208
SsoPCNA2 1.4/228 1.8/210 1.5/220
SsoPCNA3 1.7/226 1.3/224
Figure 3
SsoPCNA3 is displaced from the ring relative to the observation for the huPCNA homotrimer (PDB code 1vym; Kontopidis et al., 2005). The SsoPCNA trimer is coloured as
in Fig. 2(a); the human trimer is coloured cyan, wheat and pale pink. The same displacement is seen when compared with the yeast homotrimer (Krishna et al., 1994). The
structures are shown in stereoview.
Figure 4
Stereoview of surface properties coloured by electrostatic potential of SsoPCNA. The orientation of the molecule is the same as in Fig. 2(a). 1 denotes the likely binding site
for accessory proteins which bind to SsoPCNA1, 2 for SsoPCNA2 and 3 for SsoPCNA3.SsoPCNA2 interface, has a signiﬁcance of only 0.24, indicating the
complex is context-sensitive, in agreement with biological data
(Dionne et al., 2003). This interface, although it has a number of
speciﬁc hydrogen bonds, is signiﬁcantly polar and hence less
favourable. The SsoPCNA1–SsoPCNA3 interface has a signiﬁcance
of 0.27, suggesting that it too is context-sensitive and will only form in
the presence of the SsoPCNA1–SsoPCNA2 heterodimer; once again,
this agrees with solution data (Dionne et al., 2003), which indicates
that SsoPCNA3 does not bind strongly to either SsoPCNA1 or
SsoPCNA2 on their own and binds the heterodimer comparatively
weakly (Dionne et al., 2003). For comparison, the interfaces in
huPCNA have a signiﬁcance of 0.47, which is in the ‘grey’ area
between stable and unstable. Strikingly, then, the SsoPCNA1–
SsoPCNA2 heterodimer appears to be signiﬁcantly more stable than
even the human homotrimer. The homodimeric interfaces in
StoPCNA3 have a signiﬁcance of 0 (the lowest), agreeing with solu-
tion data that these are crystal contacts with no biological relevance
(Dionne et al., 2003).
4. Discussion
Peptide soaks and co-complexes of huPCNA (Bruning & Shamoo,
2004; Sakurai et al., 2005; Bowman et al., 2004; Kontopidis et al., 2005)
indicate that the accessory proteins bind to the loop which connects
the domains within the monomer on top of the trimer, the IDCL. The
interaction is centred on Leu126, a conserved hydrophobic residue
(Fig. 1). The homotrimer of course presents three identical IDCLs,
but the heterotrimer presents three distinct interfaces. These inter-
faces are known to interact with different proteins, conferring a
degree of control of selectivity in crenarchaea that is not possible for
the eukaryotic protein (Dionne et al., 2003). In SsoPCNA1, the IDCL
has an insertion of three amino acids compared with other archaeal
and eukaryotic sequences (Fig. 1) and is assumed to be distinct. In our
structure, this loop is disordered and cannot be modelled reliably. In
SsoPCNA2 the IDCL is mainly hydrophobic with a positively
charged patch, whereas in SsoPCNA3 this region is more negatively
charged (Fig. 4). The structure conﬁrms that the heterotrimer does
indeed present three different attachment sites. The identity of the
interacting residues cannot be inferred from either this structure or
from sequence alignment. As would be expected for a molecule
which interacts with DNA, the inner surface of the ring is positively
charged (SsoPCNA1 residues Lys10, Lys81, Lys175, Lys183, Lys206,
Lys210; SsoPCNA2 residues Arg16, Lys80, Arg81, Lys206, Arg208,
Arg209; SSoPCNA3 residues Arg24, Lys27, Arg35, Lys91, Lys94,
Lys97, Arg98, Lys99, Arg122, Lys155, Lys224). The asymmetry of the
heterotrimer is clearly visible when looking at the central hole. This
hole is narrower in SsoPCNA1 (Fig. 4) than in the other two
monomers.
SsoPCNA1 appears to be structurally distinct from the other two
monomers. It may be that this monomer must be capable of a
structural deformation to accommodate SsoPCNA3 in forming the
heterotrimer. In support of this hypothesis, we make the following
observations. Firstly, SsoPCNA2 and SsoPCNA3 are structurally
similar to each other and to StoPCNA3, implying that these mono-
mers are not sensitive to the quite different packing arrangements
they ﬁnd themselves in. The interface between SsoPCNA3 and
SsoPCNA1 is weak and suboptimal, according to analysis of both the
crystal structure andsolution measurements (Dionne et al., 2003), and
this is mirrored by the displacement of SsoPCNA3 from the plane of
the ring (compared with the human and yeast structures). Finally, the
N-terminal domain of SsoPCNA1 that is in contact with SsoPCNA3 is
partly disordered, suggesting that the domain is indeed mobile.
5. Conclusions
The crenarchaeal PCNA molecule is unusual in being more complex
than its eukaryotic equivalent. The heterotrimeric organization
allows heterogeneity between the three subunits for both inter-
subunit interactions and speciﬁcity for binding partners. SsoPCNA1
and SsoPCNA2 form a stable heterodimer that then recruits a third
monomer, SsoPCNA3, to complete the characteristic ring structure.
This third molecule is only weakly bound by the dimer, allowing the
functional clamp to disassemble and re-assemble quite easily.
SsoPCNA1 appears to have a distinct structure and plays the key role
in SsoPCNA assembly.
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